Literature DB >> 16778154

Current state of human embryonic stem cell research: an overview of cell lines and their use in experimental work.

Anke Guhr1, Andreas Kurtz, Kelley Friedgen, Peter Löser.   

Abstract

Research in human embryonic stem cells (hESCs) is a rapidly developing scientific field. In this study we collect and evaluate a thorough body of data on the current number of publicly disclosed hESC lines and the extent and impact of scientific work involving the use of these cells. These data contribute to the substantiation of the discussion on the current status of hESC research, provide a basis for the analysis of the status of such research, and uncover further needs in terms of registration, banking, standardization, and tracing.

Entities:  

Mesh：

Year:  2006        PMID： 16778154     DOI： 10.1634/stemcells.2006-0053

Source DB:  PubMed          Journal:  Stem Cells        ISSN： 1066-5099            Impact factor:   6.277


  17 in total

1.  The establishment of 20 different human embryonic stem cell lines and subclones; a report on derivation, culture, characterisation and banking.

Authors:  Mikael C O Englund; Gunilla Caisander; Karin Noaksson; Katarina Emanuelsson; Kersti Lundin; Christina Bergh; Charles Hansson; Henrik Semb; Raimund Strehl; Johan Hyllner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

2.  Derivation, characterization, differentiation, and registration of seven human embryonic stem cell lines (VAL-3, -4, -5, -6M, -7, -8, and -9) on human feeder.

Authors:  Cristobal Aguilar-Gallardo; Maria Poo; Eva Gomez; Amparo Galan; Eva Sanchez; Ana Marques-Mari; Veronica Ruiz; Jose Medrano; Marcia Riboldi; Diana Valbuena; Carlos Simon
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-26       Impact factor: 2.416

Review 3.  De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications.

Authors:  Robert L Katona
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

4.  Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells.

Authors:  Zara Melkoumian; Jennifer L Weber; David M Weber; Andrei G Fadeev; Yue Zhou; Paula Dolley-Sonneville; Jiwei Yang; Liqun Qiu; Catherine A Priest; Christopher Shogbon; Arthur W Martin; Jodelle Nelson; Peter West; James P Beltzer; Santona Pal; Ralph Brandenberger
Journal:  Nat Biotechnol       Date:  2010-05-30       Impact factor: 54.908

5.  Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V.

Authors:  Tahereh Tavakoli; Xiangru Xu; Eric Derby; Yevgeniya Serebryakova; Yvonne Reid; Mahendra S Rao; Mark P Mattson; Wu Ma
Journal:  BMC Cell Biol       Date:  2009-06-05       Impact factor: 4.241

Review 6.  Whole-organ re-engineering: a regenerative medicine approach to digestive organ replacement.

Authors:  Hiroshi Yagi; Alejandro Soto-Gutierrez; Yuko Kitagawa
Journal:  Surg Today       Date:  2012-11-27       Impact factor: 2.549

7.  Scope and impact of international research in human pluripotent stem cells.

Authors:  Peter Löser; Sabine Kobold; Anke Guhr; Franz-Josef Müller; Andreas Kurtz
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

8.  Human embryonic stem cell lines and their use in international research.

Authors:  Peter Löser; Jacqueline Schirm; Anke Guhr; Anna M Wobus; Andreas Kurtz
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

Review 9.  New approaches in the differentiation of human embryonic stem cells and induced pluripotent stem cells toward hepatocytes.

Authors:  Iman Saramipoor Behbahan; Yuyou Duan; Alexander Lam; Shiva Khoobyari; Xiaocui Ma; Tijess P Ahuja; Mark A Zern
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

10.  Power-laws and the use of pluripotent stem cell lines.

Authors:  Bernhard M Schuldt; Anke Guhr; Michael Lenz; Sabine Kobold; Ben D MacArthur; Andreas Schuppert; Peter Löser; Franz-Josef Müller
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.